Hamilton Thorne Ltd
XTSX:HTL
Hamilton Thorne Ltd
Research & Development
Hamilton Thorne Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hamilton Thorne Ltd
XTSX:HTL
|
Research & Development
-$3.7m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Research & Development
-$2.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Research & Development
-$1.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-11%
|
|
|
Stryker Corp
NYSE:SYK
|
Research & Development
-$1.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Research & Development
-$2.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Research & Development
-$1.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-21%
|
|
Hamilton Thorne Ltd
Glance View
Hamilton Thorne Ltd. engages in the provision of laboratory instruments, consumables, software and services to the assisted reproductive technology (ART) and developmental biology research markets. The company is headquartered in Beverly, Massachusetts. The company went IPO on 2007-07-10. The firm's products lines include precision laser devices, imaging systems, micromanipulation systems, air purification systems, incubators, control rate freezers, and lab monitoring systems. Its GM501 product provides the In Vitro Fertilization (IVF)lab with a cell culture media solution, including oocyte handling, sperm processing, embryo culture, and cryopreservation. Its services offers a range of user needs, ranging from equipment service contract and maintenance programs, quality control testing services to manufacturers of medical devices, culture media and consumables used in IVF labs, and laboratory design and installation services. The firm's brands include Hamilton Thorne, Gynemed, Planer, IVFtech, Embryotech Laboratories, and Tek-Event.
See Also
What is Hamilton Thorne Ltd's Research & Development?
Research & Development
-3.7m
USD
Based on the financial report for Dec 31, 2022, Hamilton Thorne Ltd's Research & Development amounts to -3.7m USD.
What is Hamilton Thorne Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-19%
Over the last year, the Research & Development growth was -7%. The average annual Research & Development growth rates for Hamilton Thorne Ltd have been -17% over the past three years , -19% over the past five years .
